Last reviewed · How we verify
NCT03730831: NETPSYCH
Childhood Maltreatment, Traumatic Experiences and Stress-associated Parameters in Schizophrenia Spectrum Disorders
NA trial testing Narrative Exposure Therapy in Schizophrenia Spectrum Disorder in 10 participants. Completed in 24 October 2022.
24 October 2022
Quick facts
| Lead sponsor | University of Konstanz |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 10 |
| Start date | 1 January 2018 |
| Primary completion | 24 October 2022 |
| Estimated completion | 24 October 2022 |
| Sites | 1 location across Germany |
Drugs / interventions tested
- Narrative Exposure Therapy
Conditions studied
- Schizophrenia Spectrum Disorder — all drugs for Schizophrenia Spectrum Disorder →
- PTSD — all drugs for PTSD →
Sponsor
University of Konstanz
Who can join
Adults 18 to 65, any sex, with Schizophrenia Spectrum Disorder or PTSD. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Childhood maltreatment (CM) in psychotic disorders is associated with increased cognitive deficits, severe psychotic symptoms, and increased comorbidity. The number of different stress experiences also increases the probability of trauma-associated symptoms. Furthermore, neurobiological changes play a key role in the vulnerability of individuals with early traumas for mental and physical illnesses, among others for diseases of the schizophrenia spectrum disorder and the further course of the disease. The project is divided into two work programs and pursues: 1. A detailed recording of the course of symptoms in participants with schizophrenia spectrum disorder to link this data with a systematic recording of CM and traumatic experiences and biological data. 2. On a subsample of participants with schizophrenia spectrum disorder and a comorbid post-traumatic stress disorder (PTSD), the researchers want to investigate whether symptom traits of existing psychotic disorders, trauma-associated symptoms and cognitive functions can be influenced by a trauma-specific treatment (NET), that has been proven to be effective in the treatment of PTSD.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03730831
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Narrative Exposure Therapy
Trials testing the same drug.
- NCT07062042 — Empowering Narratives · NA · recruiting
- NCT06345053 — Presence of PTSD and Emotion Dysregulation Among Inpatients With Substance Use Disorder · NA · recruiting
- NCT04866511 — Video NET With CYP Who Witnessed Domestic Violence · NA · completed
- NCT04525469 — Feasibility Trial of Narrative Exposure Therapy (NET) for Posttraumatic Stress Disorder (PTSD) During Pregnancy · NA · completed
- NCT03781297 — Narrative Exposure Therapy Study for PTSD Among the Homeless Population · NA · completed
Other recruiting trials for Schizophrenia Spectrum Disorder
Currently open trials in the same condition.
- NCT07290738 — Transcranial Magnetic Stimulation (TMS) for Negative Symptoms in Schizophrenia Spectrum Disorders · NA · recruiting
Other University of Konstanz trials
Trials by the same sponsor.
- NCT05167097 — Mindsets and the Effectiveness of a Brief Intervention - Replication · NA · completed
- NCT04985786 — Dynamics of Risk Perception and Risk Behavior in Alcohol Use Disorder and Schizophrenia · NA · unknown
- NCT04832035 — Integration of Refugees Into Public Mental Health Care · NA · unknown
- NCT05136105 — Preventing Trauma Symptoms in the Aftermath of Sexual Abuse in Children and Adolescents in Burundi · NA · completed
- NCT04061954 — Umuryango Ukomera Uri Hamwe - Families Are Strong Together · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03730831 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Konstanz
- Last refreshed: 13 August 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03730831.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing